What kind of drugs does Otsuka make?
Otsuka Pharmaceutical is a research-driven healthcare enterprise that develops and manufactures a wide-ranging portfolio of pharmaceutical drugs, prescription medications, and specialized nutritional products. The corporation focuses heavily on central nervous system disorders, creating advanced medications for psychiatric conditions like schizophrenia and major depressive disorder, alongside treatments for cardiovascular diseases, oncology, ophthalmology, and rare renal conditions. Additionally, the company produces innovative medical foods, intravenous solutions, and well-known consumer health products, combining rigorous scientific research with advanced pharmacological engineering to address critical global medical needs.
Related FAQs
Otsuka is a significant multi-industry conglomerate, and its market capitalization, which serves as the most accurate measure of its public worth, stands at approximately ₹608.22 billion as of July 2026 [1.5.1].
Otsuka Holdings Co., Ltd. functions as a publicly traded corporate entity rather than a privately held enterprise.
The share price of Otsuka Holdings Co., Ltd. (traded on the Tokyo Stock Exchange under the ticker 4578) is approximately 11,500.00 JPY.
Otsuka Holdings Co., Ltd. trades on the Tokyo Stock Exchange under the primary stock code 4578.
Otsuka Pharmaceutical maintains a robust global neuroscience product portfolio that includes several cornerstone medications prescribed for psychiatric and neurological conditions.